FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200424218> ?p ?o ?g. }

• W4200424218 endingPage "529" @default.
• W4200424218 startingPage "518" @default.
• W4200424218 abstract "Spatiotemporal targeting of tumor-associated macrophages (TAMs) and tumor cells is emerging as a promising strategy for tumor therapy. Tumor microcalcifications that specifically bind to bisphosphonates are potentially used to design efficient relay drug delivery nanosystems to achieve spatiotemporal drug modulation. Here, we developed manganese dioxide (MnO2)-embedded and LyP-1 peptide-labeled liposomal nanoparticles (NPs) for photodynamic immunotherapy of breast cancer; zoledronic acid (Zol) was encapsulated in the hydrophilic cavity of liposomes, and a hydrophobic photosensitizer (IR780) was embedded in the phospholipid bilayer of liposomes. These Lipo Zol/IR NPs generated O2 bubbles through MnO2 in response to H2O2 in the tumor microenvironment, leading to the degradation of the liposomal membrane, which triggered the release of Zol and provided O2 for photodynamic therapy. The released Zol attached to microcalcifications and was selectively phagocytosed by TAMs, leading to the induction of death or repolarization of TAMs from the immunosuppressive M2 phenotype to the immunostimulatory M1 phenotype. The remaining liposomal fragments embedded with IR780 then preferentially targeted tumor cells through LyP-1 peptide and produced abundant reactive oxygen species (ROS) under near infrared (NIR) laser irradiation, resulting in the death of tumor cells and mild immune activation. All in vitro and in vivo studies demonstrated the effective photodynamic and immunoregulatory performance of Lipo Zol/IR NPs. STATEMENT OF SIGNIFICANCE: Spatiotemporal targeting of tumor-associated macrophages (TAMs) and tumor cells remains a challenge in tumor photodynamic immunotherapy for promoting synergy and reducing side effects. Here, we developed tumor microcalcification-mediated relay drug delivery nanoliposomes for breast cancer therapy. H2O2 in the tumor microenvironment (TME) triggers the breakage of nanoliposomes, thereby causing the separation of zoledronic acid (Zol) and the photosensitizer IR780 and allowing them to perform their respective functions. Microcalcifications enable Zol to target TAMs, resulting in immunomodulation. LyP-1 guides IR780 to target tumor cells for PDT with adequate O2 supply. These nanoliposomes enable precise spatiotemporal targeting of different types of cells in the TME and promote the synergy between immunotherapy and PDT while ensuring the effectiveness of both methods." @default.
• W4200424218 created "2021-12-31" @default.
• W4200424218 creator A5012586602 @default.
• W4200424218 creator A5019571166 @default.
• W4200424218 creator A5031320671 @default.
• W4200424218 creator A5055809196 @default.
• W4200424218 creator A5057928430 @default.
• W4200424218 creator A5060381891 @default.
• W4200424218 creator A5087022428 @default.
• W4200424218 date "2022-03-01" @default.
• W4200424218 modified "2023-10-18" @default.
• W4200424218 title "Tumor microcalcification-mediated relay drug delivery for photodynamic immunotherapy of breast cancer" @default.
• W4200424218 cites W1573646548 @default.
• W4200424218 cites W1923535459 @default.
• W4200424218 cites W2000217512 @default.
• W4200424218 cites W2008621673 @default.
• W4200424218 cites W2036402402 @default.
• W4200424218 cites W2037489902 @default.
• W4200424218 cites W2047258107 @default.
• W4200424218 cites W2047760554 @default.
• W4200424218 cites W2058837304 @default.
• W4200424218 cites W2063992586 @default.
• W4200424218 cites W2072662813 @default.
• W4200424218 cites W2094243088 @default.
• W4200424218 cites W2118969052 @default.
• W4200424218 cites W2120944127 @default.
• W4200424218 cites W2134660260 @default.
• W4200424218 cites W2140022207 @default.
• W4200424218 cites W2140388375 @default.
• W4200424218 cites W2143293161 @default.
• W4200424218 cites W2162495360 @default.
• W4200424218 cites W2189919668 @default.
• W4200424218 cites W2216262028 @default.
• W4200424218 cites W2320574135 @default.
• W4200424218 cites W2517071495 @default.
• W4200424218 cites W2585509655 @default.
• W4200424218 cites W2601357990 @default.
• W4200424218 cites W2605458001 @default.
• W4200424218 cites W2609512644 @default.
• W4200424218 cites W2736432248 @default.
• W4200424218 cites W2772326466 @default.
• W4200424218 cites W2787300529 @default.
• W4200424218 cites W2791825614 @default.
• W4200424218 cites W2793688609 @default.
• W4200424218 cites W2804669050 @default.
• W4200424218 cites W2890033260 @default.
• W4200424218 cites W2900276526 @default.
• W4200424218 cites W2905523475 @default.
• W4200424218 cites W2916814431 @default.
• W4200424218 cites W2923614237 @default.
• W4200424218 cites W2950705205 @default.
• W4200424218 cites W2998992532 @default.
• W4200424218 cites W3109474584 @default.
• W4200424218 cites W3109651272 @default.
• W4200424218 cites W3164054621 @default.
• W4200424218 cites W78501461 @default.
• W4200424218 doi "https://doi.org/10.1016/j.actbio.2021.12.014" @default.
• W4200424218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34923096" @default.
• W4200424218 hasPublicationYear "2022" @default.
• W4200424218 type Work @default.
• W4200424218 citedByCount "9" @default.
• W4200424218 countsByYear W42004242182022 @default.
• W4200424218 countsByYear W42004242182023 @default.
• W4200424218 crossrefType "journal-article" @default.
• W4200424218 hasAuthorship W4200424218A5012586602 @default.
• W4200424218 hasAuthorship W4200424218A5019571166 @default.
• W4200424218 hasAuthorship W4200424218A5031320671 @default.
• W4200424218 hasAuthorship W4200424218A5055809196 @default.
• W4200424218 hasAuthorship W4200424218A5057928430 @default.
• W4200424218 hasAuthorship W4200424218A5060381891 @default.
• W4200424218 hasAuthorship W4200424218A5087022428 @default.
• W4200424218 hasConcept C121608353 @default.
• W4200424218 hasConcept C126322002 @default.
• W4200424218 hasConcept C171250308 @default.
• W4200424218 hasConcept C178790620 @default.
• W4200424218 hasConcept C185592680 @default.
• W4200424218 hasConcept C192562407 @default.
• W4200424218 hasConcept C203014093 @default.
• W4200424218 hasConcept C2776107976 @default.
• W4200424218 hasConcept C2777701055 @default.
• W4200424218 hasConcept C2779820397 @default.
• W4200424218 hasConcept C2780674031 @default.
• W4200424218 hasConcept C2781323092 @default.
• W4200424218 hasConcept C3020616263 @default.
• W4200424218 hasConcept C502942594 @default.
• W4200424218 hasConcept C530470458 @default.
• W4200424218 hasConcept C71924100 @default.
• W4200424218 hasConcept C8891405 @default.
• W4200424218 hasConceptScore W4200424218C121608353 @default.
• W4200424218 hasConceptScore W4200424218C126322002 @default.
• W4200424218 hasConceptScore W4200424218C171250308 @default.
• W4200424218 hasConceptScore W4200424218C178790620 @default.
• W4200424218 hasConceptScore W4200424218C185592680 @default.
• W4200424218 hasConceptScore W4200424218C192562407 @default.
• W4200424218 hasConceptScore W4200424218C203014093 @default.
• W4200424218 hasConceptScore W4200424218C2776107976 @default.
• W4200424218 hasConceptScore W4200424218C2777701055 @default.
• W4200424218 hasConceptScore W4200424218C2779820397 @default.

• next